Inventor · disambiguated record
George Vladimirovich Aslanidi
Also filed as: ASLANIDI GEORGE · ASLANIDI GEORGE VLADIMIROVICH
12 granted patents·7 pending applications·265 citations·filing 2010–2023
92Inventor score
Top patents by PatentIndex Score
19 records- 0197US9725485B2AAV vectors with high transduction efficiency and uses thereof for gene therapyUNIV FLORIDA·Filed 2013·Granted Aug 8, 2017·62 cites·28 claims
- 0297US9611302B2High-transduction-efficiency RAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2013·Granted Apr 4, 2017·67 cites·20 claims
- 0396US10294281B2High-transduction-efficiency rAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2017·Granted May 21, 2019·21 cites·19 claims
- 0496US10011640B2Capsid-modified rAAV vector compositions and methods thereforUNIV FLORIDA·Filed 2014·Granted Jul 3, 2018·42 cites·14 claims
- 0595US12065467B2High-transduction-efficiency rAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2022·Granted Aug 20, 2024·2 cites·21 claims
- 0695US10934327B2Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancerUNIV FLORIDA·Filed 2017·Granted Mar 2, 2021·6 cites·21 claims
- 0795US10815279B2Capsid-modified rAAV vector compositions and methods thereforUNIV FLORIDA·Filed 2018·Granted Oct 27, 2020·10 cites·19 claims
- 0894US8679837B2Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectorsZOLOTUKHIN SERGEI·Filed 2010·Granted Mar 25, 2014·42 cites·9 claims
- 0993US10927150B2Recombinant AAV1, AAV5, and AAV6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2019·Granted Feb 23, 2021·5 cites·17 claims
- 1091US12358954B2Capsid-modified rAAV vector compositions and methods thereforUNIV FLORIDA·Filed 2022·Granted Jul 15, 2025·1 cites·20 claims
- 1190US11434260B2High-transduction-efficiency rAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2019·Granted Sep 6, 2022·3 cites·21 claims
- 1290US11124544B2AAV vectors with high transduction efficiency and uses thereof for gene therapyUNIV FLORIDA·Filed 2017·Granted Sep 21, 2021·4 cites·32 claims
- 1380US2024109938A1Recombinant aav1, aav5, and aav6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2023·Application pending·0 cites
- 1473US2016333372A1Capsid-modified, raav3 vector compositions and uses in gene therapy of human liver cancerUNIV FLORIDA·Filed 2014·Application pending·0 cites
- 1572US2021269487A1Recombinant aav1, aav5, and aav6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 1663US2019127424A1Capsid-modified raav vector compositions and methods thereforUNIV FLORIDA·Filed 2018·Application pending·0 cites
- 1760US2018030096A1Recombinant aav1, aav5, and aav6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2016·Application pending·0 cites
- 1850US2021163989A1Transduction of innate immunocompetent cells using aav6UNIV EMORY·Filed 2019·Application pending·0 cites
- 1936US2019000943A1Aav6 vectors for immunotherapyAAVET THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George Vladimirovich Aslanidi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →